Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when OPCH files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsOption Care Health reports Q2 revenue up 1.9%, raises full-year guidance, repurchases $150M
Filed July 29, 2026 · Period ending July 29, 2026 · ~1 min read
Key Changes
-
high
Repurchased $150M of shares in Q2 2026, reducing weighted average diluted shares outstanding from 164.1M to 153.5M year-over-year.
Exhibit 99.1 view on EDGAR → -
high
Q2 2026 net revenue $1,442M (up 1.9% YoY); GAAP diluted EPS $0.35 (up 12.9%); adjusted diluted EPS $0.45 (up 9.8%); adjusted EBITDA $117.5M (up 3.0%).
Exhibit 99.1 view on EDGAR → -
high
Raised full-year 2026 guidance: net revenue $5.675B–$5.775B, adjusted diluted EPS $1.85–$1.92, adjusted EBITDA $480M–$495M, operating cash flow at least $320M.
Exhibit 99.1 view on EDGAR → -
medium
Q2 2026 operating cash flow $184M; six-month operating cash flow $171.5M, more than double the $83.1M in the same 2025 period.
Exhibit 99.1 view on EDGAR → -
medium
Q3 2026 sequential guidance: net revenue growth low to mid single-digits, adjusted EBITDA growth mid single-digits versus Q2 2026.
Exhibit 99.1 view on EDGAR →
Summary
Option Care Health reported second quarter 2026 results showing modest top-line growth with stronger earnings expansion. Net revenue of $1,442 million grew 1.9% year-over-year, while GAAP diluted EPS jumped 12.9% to $0.35 and adjusted diluted EPS rose 9.8% to $0.45.
The company generated $184 million in operating cash flow during the quarter and deployed $150 million to repurchase shares, reducing the diluted share count by roughly 6.5% year-over-year. Management raised full-year 2026 guidance across all key metrics and expects sequential revenue and EBITDA growth to continue into the third quarter.
For retail holders, the combination of raised guidance and aggressive buyback activity signals management confidence in the business trajectory. The company's operating cash flow more than doubled in the first half versus the prior year, providing ample capacity for capital returns while maintaining operational flexibility. The updated full-year outlook implies continued momentum through year-end, with sequential growth expected in both revenue and profitability.
Section-by-Section Diff
Event · Exhibit 99.1
Option Care Health reported Q2 2026 earnings with 1.9% revenue growth, raised full-year guidance, and repurchased $150M in shares.
Added in current filing · view on EDGAR →
For the third quarter 2026, Option Care Health expects the following compared to the second quarter 2026:
•Sequential net revenue growth in the low to mid single-digits
•Sequential Adjusted EBITDA growth in the mid single-digits
This guidance indicates continued momentum in the business through the second half of the year.
Event · Item 2.02 — Results of Operations and Financial Condition
Option Care Health reported Q2 2026 financial results via press release; specific figures not disclosed in 8-K body.
Added in current filing · verify on EDGAR →
On July 29, 2026, Option Care Health, Inc. issued a press release reporting its second quarter 2026 financial results.
The company announced its second quarter 2026 financial results through a press release. The 8-K body does not contain the actual financial figures; those are in the attached Exhibit 99.1 press release, which is furnished but not filed.
Added in current filing · verify on EDGAR →
The press release includes certain non-GAAP financial measures described therein. Reconciliation between any non-GAAP financial measures presented and the most directly comparable GAAP financial measures is also provided.
The company disclosed that the earnings press release contains non-GAAP financial measures with reconciliations to GAAP. This is standard practice for earnings announcements to provide adjusted metrics alongside GAAP results.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jul 30, 2026 · How we verify